PUBBLICATO IL NUOVO NUMERO DELLA WHO PHARMACEUTICAL NEWSLETTER



WHO PHARMACEUTICALS NEWSLETTER N. 3
Fonte: WHO. Giugno 2009



E' disponibile il nuovo numero della WHO PHARMACEUTICALS NEWSLETTER dell'Organizzazione Mondiale della Sanità.

In questo numero sono trattati i seguenti argomenti:
Regulatory Matters
• Botulinum toxins Type A and Type B
• Ceftriaxone
• Chromic Phosphate P32
• Cough and cold medicines
• Dietary supplements
• Erlotinib
• Etanercept
• Hydroxyzine hydrochloride
• Salicylate containing oral gels
• Testosterone gel products
• Trastuzumab
Safety of Medicines
• Aliskiren
• Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists
• Antiepileptics
• Antipsychotics
• Atypical antipsychotics
• Bevacizumab
• Cefaclor
• Clopidogrel
• Corticosteroids
• Flecainide
• Immunoglobulin
• Isotretinoin
• Lignocaine with Clorhexidine
• Methylthioninium chloride
• Non-steroidal anti-inflammatory drugs
• Phosphate containing laxatives
• Red yeast rice extract
• Selective serotonin reuptake inhibitors
• Sodium valproate
• Varenicline
Feature
• Advisory Committee on Safety of Medicinal Products (ACSoMP)